|Bid||1.0600 x 301800|
|Ask||1.0700 x 308300|
|Day's Range||1.0500 - 1.1200|
|52 Week Range||0.1380 - 3.9600|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 11, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||0.76|
Case in point: The much-maligned Sundial Growers (NASDAQ: SNDL) recently took advantage of its WallStreetBets-driven share price surge to issue a boatload of new stock and warrants, thereby raising enough money to completely change the trajectory of the company. Currently a business that is focused on growing cannabis for sale in Canada, Sundial is now in a position to go global -- but not in the way that investors might expect. Sunstream Bancorp, the joint venture Sundial announced in March with Canadian alternative investment management firm SAF Group, aims to make money by issuing loans and investing in cannabis companies and marketable securities.
You have to give props to Sundial Growers (NASDAQ: SNDL) and Tilray (NASDAQ: TLRY) for their impressive share-price gains so far this year. Sure, Sundial and Tilray aren't close to their peaks set earlier in 2021. Here are three ways Trulieve trounces both Sundial and Tilray.
Shares of Sundial Growers (NASDAQ: SNDL), Clover Health (NASDAQ: CLOV), and AMC Holdings (NYSE: AMC) are getting hit hard in Thursday trading. In the case of at least two of these stocks, there is. First off, AMC announced Wednesday night that it had a new, updated share count to report.